scispace - formally typeset
J

Jana Markova

Researcher at Charles University in Prague

Publications -  97
Citations -  3144

Jana Markova is an academic researcher from Charles University in Prague. The author has contributed to research in topics: BEACOPP & ABVD. The author has an hindex of 22, co-authored 86 publications receiving 2690 citations. Previous affiliations of Jana Markova include Czech Hydrometeorological Institute.

Papers
More filters
Journal ArticleDOI

Fusion of the additional sex combs like 1 and teashirt zinc finger homeobox 2 genes resulting from ider(20q) aberration in a patient with myelodysplastic syndrome

Jana Brezinova, +9 more
- 01 Jan 2014 - 
TL;DR: The results confirmed that total body iron in HIV-positive and HIV-negative Zimbabwean newborns strongly predicts anemia throughout infancy and is predicted by maternal hemoglobin concentration.
Journal ArticleDOI

Urban Parks Hydrological Regime in the Context of Climate Change—A Case Study of Štěpánka Forest Park (Mladá Boleslav, Czech Republic)

Petr Kupec, +5 more
- 11 Mar 2022 - 
TL;DR: In this article , the authors present the results of a case study that was prepared as a basis for decision-making processes in the context of the impacts of global climate change on urban forests.
Journal ArticleDOI

DNMT3A mutations in AML: a new prognostic factor?

Jiří Schwarz, +1 more
- 01 Nov 2013 - 
TL;DR: The aim of the metaanalysis was to increase robustness of the prognostic ata on DNMT3A mutations in AML so as to be able to advoate their testing at diagnosis of AML, and it seems that Shivarov et al. fulfilled the aim by demonstrating the utations’ influence even on OS.
Journal ArticleDOI

ASXL1 gene alterations in patients with isolated 20q deletion.

Jana Brezinova, +14 more
- 23 Jul 2019 - 
TL;DR: A combination of molecular cytogenetic methods was used to confirm ASXL1 gene alterations in 19 of the 36 patients, and the determination of AS XL1 gene changes in patients with deletion 20q revealed clinical and prognostic impacts.
Journal Article

Eight Cycles of Escalated-Dose BEACOPP Compared With FourCycles of Escalated-Dose BEACOPP Followed by Four Cycles ofBaseline-Dose BEACOPP With or Without Radiotherapy in PatientsWith Advanced-Stage Hodgkin’s

Peter Borchmann, +19 more
- 01 Jan 2011 - 
TL;DR: The reduction of BEACOPP to the 4 + 4 regimen did not substantially reduce severe toxicity but might decrease efficacy, and the results do not support the omission of consolidation RT for patients with residual disease.